Cargando…
New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5)
Cluster of differentiation 40 (CD40) is a member of the tumour necrosis factor family and a new immune-modulating target in cancer treatment. B cells, myeloid cells and dendritic cells can express CD40 and mediate via the ligand cluster of differentiation 40 ligand (CD40L) cytotoxic T cell priming u...
Autores principales: | Piechutta, Manuel, Berghoff, Anna Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579575/ https://www.ncbi.nlm.nih.gov/pubmed/31275618 http://dx.doi.org/10.1136/esmoopen-2019-000510 |
Ejemplares similares
-
Glucocorticoid-Induced TNFR-Related Protein Stimulation Reverses Cardiac Allograft Acceptance Induced by CD40-CD40L Blockade
por: Krill, Kenneth T., et al.
Publicado: (2013) -
New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
por: Starzer, Angelika M., et al.
Publicado: (2020) -
Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
por: Yang, Fan, et al.
Publicado: (2021) -
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
por: Bosmans, Laura A., et al.
Publicado: (2020) -
Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40-mediated STAT1 and NF-κB activation
por: Bagnati, Marta, et al.
Publicado: (2016)